Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Julian Legg

Associate Professor

University of Southampton

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Biostatistics Biostatistics professors in United Kingdom

Articles (11)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Collaborators (8)

Edward F. McKone

IRELAND

View details

Thomas Daniels

University of Southampton

UNITED KINGDOM

View details

Manu Jain

Northwestern University

UNITED STATES

View details

Jo Corbett

Academic, Head, Interim Head of Research

University of Portsmouth

UNITED KINGDOM

View details

IOANNIS VOGIATZIS

PROFESSOR IN REHABILITATION SCIENCES

Northumbria University

UNITED KINGDOM

View details

Anna-Maria Dittrich

Ärzte

Hannover Medical School

GERMANY

View details

Zoe Saynor

Academic, Reader, Reader in Clinical Exercise Physiology

University of Portsmouth

UNITED KINGDOM

View details

Dia Soilemezi

University of Portsmouth

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Julian Legg

Research Interests

Explore related searches

Articles (11)

Exploring Exercise as Airway Clearance in Cystic Fibrosis: A Qualitative Study From the ExACT‐CF Feasibility Trial

Fifteen-minute consultation: Diagnosing and managing protracted bacterial bronchitis in children and young people

Measurement of lung clearance index (LCI2.5) by nitrogen multiple breath washout (N2-MBW) is feasible and well‍-‍tolerated by adults and children with cystic fibrosis

Cardiovascular function in people with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor: A cross-sectional, observational, single-centre study

Peripheral muscle function and body composition in people with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor: a cross‐sectional single‐centre study

Safety, feasibility and efficacy of exercise as an airway clearance technique in cystic fibrosis: a randomised pilot feasibility trial

Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials.

Elexacaftor/tezacaftor/ivacaftor in children aged ≥6 years with cystic fibrosis heterozygous for F508del and a minimal function mutation: results from a 96-week open-label extension study

Elevated liver function tests in infants exposed to elexacaftor-tezacaftor-ivacaftor in utero and while breastfeeding – Case reports

Real-world impact of Elexacaftor-Tezacaftor-Ivacaftor treatment in young people with Cystic Fibrosis: A longitudinal study

Causal Analysis of Physiological Sleep Data Using Granger Causality and Score-Based Structure Learning

Collaborators (8)

Edward F. McKone

Thomas Daniels

Manu Jain

Jo Corbett

IOANNIS VOGIATZIS

Anna-Maria Dittrich

Zoe Saynor

Dia Soilemezi

Make your next move.